Published in Public Health Genomics on November 26, 2009
Personal genomic information management and personalized medicine: challenges, current solutions, and roles of HIM professionals. Perspect Health Inf Manag (2014) 0.79
Preconception interventions in infertile couples. J Educ Health Promot (2014) 0.75
Expanded carrier screening in an infertile population: how often is clinical decision making affected? Genet Med (2016) 0.75
Evaluation of two-year Jewish genetic disease screening program in Atlanta: insight into community genetic screening approaches. J Community Genet (2015) 0.75
The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med (2003) 7.94
Recommendations to improve preconception health and health care--United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recomm Rep (2006) 6.56
Race and genomics. N Engl J Med (2003) 6.19
Methodologies for improving response rates in surveys of physicians: a systematic review. Eval Health Prof (2007) 5.15
Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51
Carrier screening in individuals of Ashkenazi Jewish descent. Genet Med (2008) 4.13
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med (2001) 3.72
Genetic variation, classification and 'race'. Nat Genet (2004) 2.63
Genetic influences on health: does race matter? JAMA (2005) 2.28
Preconception care for improving perinatal outcomes: the time to act. Matern Child Health J (2006) 1.93
What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era. Nat Genet (2004) 1.85
Retracted ACOG Committee Opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosis. Obstet Gynecol (2005) 1.42
ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy. Obstet Gynecol (2007) 1.41
Racial categories in medical practice: how useful are they? PLoS Med (2007) 1.37
Preconception healthcare: what women know and believe. Matern Child Health J (2006) 1.34
Preconceptional health promotion: progress in changing a prevention paradigm. J Perinat Neonatal Nurs (2004) 1.20
CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med (2004) 1.19
ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol (2004) 1.15
The Cystic Fibrosis mutation "arms race": when less is more. Genet Med (2007) 1.06
The feasibility of using ethnicity as a primary tool for antenatal selective screening for sickle cell disorders: pointers from the research evidence. Soc Sci Med (2003) 1.03
National recommendations for preconception care: the essential role of the family physician. J Am Board Fam Med (2007) 1.00
The clinical content of preconception care: genetics and genomics. Am J Obstet Gynecol (2008) 0.98
Where is the "W"oman in MCH? Am J Obstet Gynecol (2008) 0.95
The practitioner's dilemma: can we use a patient's race to predict genetics, ancestry, and the expected outcomes of treatment? Ann Intern Med (2005) 0.91
Linking family history in obstetric and pediatric care: assessing risk for genetic disease and birth defects. Pediatrics (2007) 0.89
The future is now: carrier screening for all populations. Genet Med (2008) 0.89
ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease. Obstet Gynecol (2005) 0.89
The history of preconception care: evolving guidelines and standards. Matern Child Health J (2006) 0.88
Ethnic intermarriage and its consequences for cystic fibrosis carrier screening. Am J Prev Med (1996) 0.79
Family physicians' beliefs about genetic contributions to racial/ethnic and gender differences in health and clinical decision-making. Community Genet (2008) 0.79
Genetic risks to the mother and the infant: assessment, counseling, and management. Matern Child Health J (2006) 0.79
A five-step "microskills" model of clinical teaching. J Am Board Fam Pract (1992) 3.94
Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin Pharmacol Ther (1987) 2.92
Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet (1974) 2.29
Differences in preconceptional and prenatal behaviors in women with intended and unintended pregnancies. Am J Public Health (1998) 2.05
Hereditary aspects of malignant melanoma. JAMA (1967) 1.98
Smoking cessation in women concerned about weight. Am J Public Health (1992) 1.79
Considerations for designing a prototype genetic test for use in translational research. Public Health Genomics (2009) 1.67
Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med (2001) 1.58
Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer (1977) 1.57
Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiol Biomarkers Prev (2000) 1.54
Malignant melanoma: the patient with an unknown site of primary origin. Arch Surg (1975) 1.51
Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res (1983) 1.47
What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Public Health Genomics (2009) 1.45
Community attitudes toward public policies to control alcohol, tobacco, and high-fat food consumption. Am J Prev Med (1990) 1.45
The impact of smoking and quitting on health care use. Arch Intern Med (1995) 1.35
Stress, depressive symptoms, and smoking cessation among pregnant women. Health Psychol (2000) 1.34
Cancer of the right lobe of the liver: a variety of operative procedures. Arch Surg (1972) 1.30
Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis. Surgery (1976) 1.30
Maternal smoking cessation and relapse prevention during health care visits. Am J Prev Med (2001) 1.18
Axillary metastases from unknown primary sites. Ann Surg (1973) 1.17
Do weight concerns hinder smoking cessation efforts? Addict Behav (1992) 1.16
Immune reactivity of lymphoid tissues adjacent to carcinoma of the ascending colon. Surg Gynecol Obstet (1974) 1.13
Excision of underlying fascia with a primary malignant melanoma: effect on recurrence and survival rates. Surgery (1982) 1.13
Relapse prevention for smoking cessation: review and evaluation of concepts and interventions. Annu Rev Public Health (1994) 1.13
Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res (1973) 1.09
Sarcomas of the limbs. Results of adjuvant chemotherapy using isolation perfusion. Arch Surg (1974) 1.05
Promoting smoking abstinence in pregnant and postpartum patients: a comparison of 2 approaches. Am J Manag Care (2001) 1.04
The Back Injury Prevention Project pilot study. Assessing the effectiveness of back attack, an injury prevention program among nurses, aides, and orderlies. J Occup Med (1993) 1.02
The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J Virol (1996) 1.02
Ineffective use of condoms among young women in managed care. AIDS Care (2002) 1.01
Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity. Nat New Biol (1973) 1.01
Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil. Lancet (1976) 0.99
Microbial skin flora of selected cancer patients and hospital personnel. J Clin Microbiol (1976) 0.99
The effect of differences in objective and subjective definitions of childhood physical abuse on estimates of its incidence and relationship to psychopathology. Child Abuse Negl (1994) 0.97
The shortened premenstrual assessment form. J Reprod Med (1991) 0.97
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results. Cancer (1975) 0.97
The natural history of resectable metastatic melanoma (Stage IVA melanoma). Cancer (1982) 0.96
Tobacco, alcohol, and caffeine use and cessation in early pregnancy. Am J Prev Med (2000) 0.96
Aerobic fitness testing: an update. Occup Health (Lond) (1996) 0.94
Associations between early experiences with parents and well-being in old age. J Gerontol (1993) 0.92
Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities. Cancer (1976) 0.92
A genetic test registry: bringing credible and actionable data together. Public Health Genomics (2009) 0.91
The natural history of gastric cancer and prognostic factors influencing survival. J Clin Oncol (1984) 0.91
Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs. Ann Surg (1975) 0.90
Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene. Am J Hum Genet (1993) 0.89
Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum Gene Ther (1999) 0.89
Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin Pharmacol Ther (1985) 0.89
Finding a place for genomics in health disparities research. Public Health Genomics (2012) 0.88
Racial differences in physician recommendation of hormone replacement therapy. Prev Med (2001) 0.87
Adenocarcinoma of the stomach: are we making any progress? South Med J (1987) 0.87
The use of commercial tanning facilities by suburban Minnesota adolescents. Am J Public Health (1994) 0.87
Microsatellite instability, prognosis and metastasis in gastric cancers from a low-risk population. Int J Cancer (2000) 0.86
Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer. Mol Pathol (2003) 0.86
Carcinoma in the other breast. South Med J (1970) 0.86
Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigen. Proc Soc Exp Biol Med (1972) 0.85
Palliative total gastrectomy and esophagogastrectomy. A reevaluation. Cancer (1983) 0.85
Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro. Cancer Res (1972) 0.85
An unusual ocular complication after anesthesia. Anesthesiology (1975) 0.85
Pelvic recurrence of cancer after abdominoperineal resection of the rectum. South Med J (1979) 0.85
Women's perceived and partners' reported support for smoking cessation during pregnancy. Ann Behav Med (2001) 0.84
Antinucleolar antibodies in the sera of patients with malignant melanoma. Surg Forum (1972) 0.84
Breast cancer: a critical review of a patient sample with a ten-year follow-up. South Med J (1975) 0.84
Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method. Toxicology (2001) 0.84
Conformation of the cytoplasmic domain of phospholamban by NMR and CD. Mol Membr Biol (1995) 0.83
Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy. Int J Cancer (1974) 0.83
The surgeon as oncologist. South Med J (1978) 0.83
Cancer of the colon: a comparison of survival factors. South Med J (1974) 0.82
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer. Ann N Y Acad Sci (1976) 0.82
Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens. Natl Cancer Inst Monogr (1973) 0.82
Experience with 1-phenylalanine mustard dihydrochloride in isolation-perfusion of extremities for malignant melanoma. Cancer (1971) 0.82
Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans. Cancer Res (1983) 0.82
Perfusion treatment for malignant melanoma of the extremity. Arch Chir Neerl (1970) 0.81
Nonsuture repair of pelvic fistulae. An experimental study. Tex Med (1970) 0.81
The impact of familial environment on depression scores after genetic testing for cancer susceptibility. Clin Genet (2008) 0.81
Angiosarcoma in the lymphedematous limb. South Med J (1969) 0.81
Chronic myelogenous leukemia: management of splenectomy in a high-risk population. Cancer (1977) 0.81
Hepatic arterial infusion of Corynebacterium parvum and chemotherapy. Surg Gynecol Obstet (1978) 0.81
Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation. Clin Genet (2011) 0.81
Freedom from fat: a contemporary multi-component weight loss program for the general population of obese adults. J Am Diet Assoc (1989) 0.81
Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer (1987) 0.81
Hepatic hyperthermia by total isolation and regional perfusion in vivo. J Surg Res (1979) 0.81
Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. Am J Surg (1986) 0.80
Surgical versus nonsurgical management of metastatic melanoma of the brain. Neurosurgery (1980) 0.80
Immunocompetence, immunodeficiency and prognosis in cancer. Ann N Y Acad Sci (1976) 0.80
Management of malignant melanoma. Adv Surg (1974) 0.80
Further observations on tissue heating patterns using an invasive ground probe with radiofrequency hyperthermia system. Med Instrum (1984) 0.80
Secondary inflammatory breast cancer: treatment options. South Med J (1988) 0.80
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusion. Invest New Drugs (1985) 0.79
Lymphocyte blastogenic responses to autochthonous viable and nonviable human tumor cells. J Natl Cancer Inst (1973) 0.79
Malignant melanoma in children and young adults: effect of diagnostic criteria on staging and end results. South Med J (1978) 0.79
Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients. South Med J (1988) 0.79
Effect of a novel air disinfection system on airborne micro-organisms in a hospital outpatient clinic. J Hosp Infect (2011) 0.78
Perceptions of menopausal stage and patterns of hormone replacement therapy use. J Womens Health (1997) 0.78
Effectiveness of podcasts as an adjunct learning strategy in teaching clinical microbiology among medical students. J Hosp Infect (2010) 0.78
Attitudes toward smoking and family-based health promotion among rural mothers and other primary caregivers who smoke. J Sch Health (2001) 0.78
Hyperkalemic periodic paralysis with cardiac dysrhythmia: a novel sodium channel mutation? Ann Neurol (1995) 0.78
Gastric cancer. Am J Surg (1989) 0.78
Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma. Cancer (1973) 0.78
Combined modality therapy of malignant melanoma. World J Surg (1979) 0.78
Skin cancer concerns and genetic risk information-seeking in primary care. Public Health Genomics (2011) 0.78